vcfirmsdirectory.com

Venture capital · Early stage · Est. 2021

Monograph Capital

Monograph Capital is a transatlantic life sciences investment firm with offices in London and San Francisco. It finds, funds and builds innovative therapeutics and healthcare companies.

London · San Francisco · Fort WorthRegistered · San Francisco
New investments · 12 months
Fund vehiclesPublic
2
2 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: monograph.bio · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Monograph Capital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Monograph Capital right for your round?

Is Monograph Capital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
2
2 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

MONOGRAPH CAPITAL PARTNERS II, L.P.US private fund · Active · United States · $168.3M gross assets · filed 25 Mar 2026
MONOGRAPH CAPITAL PARTNERS I, L.P.US private fund · Active · United States · $157.2M gross assets · filed 25 Mar 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Monograph Capital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

2 rounds in the last 12 months

Round sizes, Monograph Capital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

Ascend Advanced TherapiesAutobahnAviadoBioMaxion TherapeuticsNocion TherapeuticsOllin BiosciencesODAIAOuro MedicinesProlynxSudoand 5 more

Portfolio and exits

Every company Monograph Capital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Monograph Capital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Monograph Capital

Events where Monograph Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Monograph Capital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

24 Jun 2026New deal
25 Mar 2026Fund filingForm ADV filed by MONOGRAPH CAPITAL ADVISORS (UK), LLP.SEC Form ADV · public record
25 Mar 2026Fund filingForm ADV filed by MONOGRAPH CAPITAL ADVISORS, L.P.: 2 private funds, $325.5M in gross assets.SEC Form ADV · public record
7 Jan 2026New deal
3 Mar 2024New deal

Founders also look at

Frequently asked questions

Monograph Capital is based in San Francisco, United States. It also has offices in London and Fort Worth.

In 2021.

2 fund vehicles are on public registers (SEC adviser filings), including MONOGRAPH CAPITAL PARTNERS II, L.P. and MONOGRAPH CAPITAL PARTNERS I, L.P.

Stages: Series A. Sectors: Life sciences, Biotech, Medtech. From the firm’s own website.

Monograph looks for leading scientific innovation and helps build strong companies across the Atlantic. It combines differentiated sourcing, long-standing pharma relationships, deep medical expertise and operating experience to turn promising science into treatments for patients. From the firm’s own website.

Monograph Capital lists 15 portfolio companies on its website, including Ascend Advanced Therapies, Autobahn, AviadoBio, Maxion Therapeutics and Nocion Therapeutics.

Firms whose websites list some of the same companies include Advent Life Sciences, 5AM Ventures and DCVC.

Know before Monograph Capital’s next round is announced.

PRO tracks Monograph Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Monograph CapitalGet Monograph Capital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.